Novel Use of Active Leptospermum Honey for Ringed Fixator Pin Site Care in Diabetic Charcot Deformity Patients

Abstract

Introduction. Open reduction with external fixation (OREF) utilizing fine wire ringed fixators for correction of Charcot deformity has gained popularity over the past decade. Pin site infections are a well-documented complication of external fixation as well as a driver of escalating health care costs. We aimed to demonstrate the safety and efficacy of a novel method of pin site care utilizing active Leptospermum honey–impregnated dressings (MediHoney) in diabetic patients undergoing deformity correction with OREF. Methods. Twenty-one diabetic patients with Charcot deformities of the lower extremity were prospectively enrolled and followed for pin site complications following OREF for deformity correction. Active Leptospermum honey dressings were applied at metal-cutaneous interfaces at the end of the OREF procedure and replaced weekly for a total of 8 weeks. Patients were monitored for pin site infections from the time of surgery until external fixator removal. Sixteen consecutive patients receiving standard OREF for Charcot deformities were evaluated retrospectively to serve as a control group. Results. Of the 21 enrolled patients, 19 underwent OREF and followed up throughout the study period. Treated patients had a mean age of 58.5 years and mean body mass index measuring 33.3 kg/m² as documented prior to surgery. The 15 patients with hemoglobin A1c labs drawn in the 3 months preceding surgery averaged 7.5. Fixators were removed at an average of 12.1 weeks after adequate bony healing. Of the 244 pin sites in 19 patients, 3 pin sites (1.2% of pins) in 2 patients (10.5% of patients) showed evidence of superficial infection. All infections resolved with oral antibiotics. Infection rates were significantly reduced when compared to the standard care control group. Conclusions. Pilot data in a prospectively collected case series demonstrate safety and efficacy of active Leptospermum honey–impregnated dressings when used for fine wire ringed fixator pin site care in diabetic Charcot deformity patients. Further investigation in the form of a prospective randomized controlled study is warranted to demonstrate the potential value of this novel intervention.

Levels of Evidence: Level IV

Keywords

osteomyelitis arthritis and joint disease diabetes wound care

Get full access to this article

View all access options for this article.

References

Cam

Demir Korkmaz

Oner Savk

. Effects of two different solutions used in pin site care on the development of infection. Acta Orthop Traumatol Turc. 2014;48:80-85.

Finkler

Kasia

Kroin

Davidson-Bell

Schiff

Pinzur

. Pin tract infection following correction of Charcot foot with static circular fixation. Foot Ankle Int. 2015;36:1310-1315.

Gil

Schiff

Pinzur

. Cost comparison: limb salvage versus amputation in diabetic patients with Charcot foot. Foot Ankle Int. 2013;34:1097-1099.

Mahan

Seligson

Henry

Hynes

Dobbins

. Factors in pin tract infections. Orthopedics. 1991;14:305-308.

Parameswaran

Roberts

Seligson

Voor

. Pin tract infection with contemporary external fixation: how much of a problem? J Orthop Trauma. 2003;17:503-507.

Saw

Chan

Penafort

Sengupta

. A simple practical protocol for care of metal-skin interface of external fixation. Med J Malaysia. 2006;61(suppl A):62-65.

Pinzur

. Neutral ring fixation for high-risk nonplantigrade Charcot midfoot deformity. Foot Ankle Int. 2007;28:961-966.

Pinzur

Gil

Belmares

. Treatment of osteomyelitis in charcot foot with single-stage resection of infection, correction of deformity, and maintenance with ring fixation. Foot Ankle Int. 2012;33:1069-1074.

Basson

Grobler

. Antimicrobial activity of two South African honeys produced from indigenous Leucospermum cordifolium and Erica species on selected micro-organisms. BMC Complement Altern Med. 2008;8:41.

10.

Betts

. The clinical application of honey in wound care. Nurs Times. 2008;104:43-44.

11.

Bischofberger

Dart

Perkins

Kelly

Jeffcott

Dart

. The effect of short- and long-term treatment with manuka honey on second intention healing of contaminated and noncontaminated wounds on the distal aspect of the forelimbs in horses. Vet Surg. 2013;42:154-160.

12.

Blair

Cokcetin

Harry

Carter

. The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis. Eur J Clin Microbiol Infect Dis. 2009;28:1199-1208.

13.

Irish

Blair

Carter

. The antibacterial activity of honey derived from Australian flora. PLoS One. 2011;6:e18229.

14.

Jenkins

Cooper

. Improving antibiotic activity against wound pathogens with manuka honey in vitro. PLoS One. 2012;7:e45600.

15.

Majtan

Bohova

Horniackova

Klaudiny

Majtan

. Anti-biofilm effects of honey against wound pathogens Proteus mirabilis and Enterobacter cloacae. Phytother Res. 2014;28:69-75.

16.

Muller

Alber

Turnbull

et al

Synergism between MediHoney and rifampicin against methicillin-resistant Staphylococcus aureus (MRSA). PLoS One. 2013;8:e57679.

17.

Packer

Irish

Herbert

et al

Specific non-peroxide antibacterial effect of manuka honey on the Staphylococcus aureus proteome. Int J Antimicrob Agents. 2012;40:43-50.

18.

Tomblin

Ferguson

Han

Murray

Schlothauer

. Potential pathway of anti-inflammatory effect by New Zealand honeys. Int J Gen Med. 2014;7:149-158.

19.

Tonks

Dudley

Porter

et al

A 5.8-kDa component of manuka honey stimulates immune cells via TLR4. J Leukoc Biol. 2007;82:1147-1155.

20.

Bardy

Molassiotis

Ryder

et al

A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis. Br J Oral Maxillofac Surg. 2012;50:221-226.

21.

Boyar

Handa

Clemens

Shimborske

. Clinical experience with Leptospermum honey use for treatment of hard to heal neonatal wounds: case series. J Perinatol. 2014;34:161-163.

22.

Chambers

. Topical manuka honey for MRSA-contaminated skin ulcers. Palliat Med. 2006;20:557.

23.

Dunford

. Treatment of a wound infection in a patient with mantle cell lymphoma. Br J Nurs. 2001;10:1058, 1060, 1062, 1064-1065.

24.

Ganacias-Acuna

. Active Leptospermum honey and negative pressure wound therapy for nonhealing postsurgical wounds. Ostomy Wound Manage. 2010;56(3):10-12.

25.

Gethin

Cowman

. Case series of use of manuka honey in leg ulceration. Int Wound J. 2005;2:10-15.

26.

Gray

Ishii

. Using active Leptospermum honey in the debridement process: 6 challenging cases from the inner city. Ostomy Wound Manage. 2015;61(4):63-66.

27.

Robson

Cooper

. Using leptospermum honey to manage wounds impaired by radiotherapy: a case series. Ostomy Wound Manage. 2009;55(1):38-47.

28.

Robson

Yorke

Sen

Lowe

Rogers

. Randomised controlled feasibility trial on the use of medical grade honey following microvascular free tissue transfer to reduce the incidence of wound infection. Br J Oral Maxillofac Surg. 2012;50:321-327.

29.

Rudzka-Nowak

Luczywek

Gajos

Piechota

. Application of manuka honey and GENADYNE A4 negative pressure wound therapy system in a 55-year-old woman with extensive phlegmonous and necrotic lesions in the abdominal integuments and lumbar region after traumatic rupture of the colon. Med Sci Monit. 2010;16:CS138-CS142.

30.

Amaya

. Safety and efficacy of active Leptospermum honey in neonatal and paediatric wound debridement. J Wound Care. 2015;24(3):95, 97-103.

31.

Mohr

Reyna

Amaya

. Neonatal case studies using active Leptospermum honey. J Wound Ostomy Continence Nurs. 2014;41:213-218.

32.

Ktistakis

Guerado

Giannoudis

. Pin-site care: can we reduce the incidence of infections? Injury. 2015;46(suppl 3):S35-S39.

33.

Jennison

McNally

Pandit

. Prevention of infection in external fixator pin sites. Acta Biomater. 2014;10:595-603.

34.

Shirai

Tsuchiya

Shimizu

Ohtani

Zen

Tomita

. Prevention of pin tract infection with titanium-copper alloys. J Biomed Mater Res B Appl Biomater. 2009;91:373-380.

35.

Lucke

Schmidmaier

Sadoni

et al

Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone. 2003;32:521-531.

36.

Shirai

Shimizu

Ohtani

Zen

Takaya

Tsuchiya

. Antibacterial iodine-supported titanium implants. Acta Biomater. 2011;7:1928-1933.

37.

Harris

Mead

Muller-Oberlander

Richards

. Bacteria and cell cytocompatibility studies on coated medical grade titanium surfaces. J Biomed Mater Res A. 2006;78:50-58.

38.

Mavric

Wittmann

Barth

Henle

. Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res. 2008;52:483-489.

39.

Cooper

Jenkins

. Are there feasible prospects for manuka honey as an alternative to conventional antimicrobials? Expert Rev Anti Infect Ther. 2012;10:623-625.